Fig. 3.

Areas of research and industry which will benefit from advances in avian genome editing technology—a production of antibodies and other therapeutic proteins through precise editing of albumen-specific loci, making use of the chicken egg as a pharmaceutical bioreactor. b Gene editing in non-poultry avian research models will improve our understanding in areas such as neuroplasticity and senescence. c Preservation of valuable genetics across poultry lines, through cryopreservation, and clever use of genetic information to introduce valuable traits into pre-existing lines